Multiple variants of SARS-CoV-2 are circulating globally and posting new challenges to human health. As concerns over the potential impacts of the variants grow, the deleloped of effcient treatment agaginst multiple variants of SARS-CoV-2 is an emergent need for global pubic heath.It is necessary to develop SARS-CoV-2 inhibitors, such as vaccines、therapeutic antibodies and small molecule compounds against SARS-CoV-2(B.1.1.7). Therefore, it is helpful to develop the SARS-CoV-2 (B.1.1.7) Inhibitor Screening Kit (Spike RBD) to test SARS-CoV-2 inhibitors.
Application
This kit is developed for screening inhibitors of SARS-CoV-2(B.1.1.7).
Reconstitution
Please see Certificate of Analysis for details of reconstitution instruction and specific concentration.
Storage
The unopened kit is stable for 12 months from the date of manufacture if stored at 2°C to 8°C.